AMANDA CAPPUCCINO: Open Payments
NPI 1558195800 · WEST CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,750 in 70 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $465 · 2025 $1,750
Food & beverage: $1,750
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $381 |
| Sumitomo Pharma America, Inc. | 17 | $300 |
| Janssen Biotech, Inc. | 7 | $289 |
| PFIZER INC. | 5 | $194 |
| TOLMAR, INC. | 6 | $118 |
| Novartis Pharmaceuticals Corporation | 3 | $80 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Olympus America Inc. | 2 | $42 |
| Antares Pharma, Inc. | 2 | $41 |
| UROGEN PHARMA, INC. | 2 | $37 |
Products named: Nubeqa, ERLEADA, GEMTESA, XTANDI, JATENZO, PLUVICTO, ORGOVYX, LYNPARZA.
Industry payments across PA — which companies pay providers there.
